These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma. Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281 [TBL] [Abstract][Full Text] [Related]
3. Pleural fluid microbiota as a biomarker for malignancy and prognosis. Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121 [TBL] [Abstract][Full Text] [Related]
4. Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion. Wen Y; Wang Y; Xing Z; Liu Z; Hou Z Cell Cycle; 2018; 17(24):2819-2832. PubMed ID: 30563416 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B. Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A; Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226 [TBL] [Abstract][Full Text] [Related]
6. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion. Ozmen ZC; Kupeli M Biochem Med (Zagreb); 2023 Oct; 33(3):030701. PubMed ID: 37841777 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion]. Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254 [No Abstract] [Full Text] [Related]
8. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion. Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074 [TBL] [Abstract][Full Text] [Related]
9. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study. Choi H; Ko Y; Lee CY BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726 [TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle MicroRNA in Malignant Pleural Effusion. Shojaee S; Romano G; Sanchez TM; Yermakhanova G; Saviana M; Le P; Nigita G; Calore F; Guthrie R; Hess K; Kang L; Swift-Scanlan T; Graham JT; Rahman NM; Nana-Sinkam PS; Acunzo M Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421832 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion. Shi XY; Yi FS; Wang Z; Qiao X; Zhai K Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion. Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464 [TBL] [Abstract][Full Text] [Related]
13. Pleural Effusion in Multiple Myeloma. Wang Z; Xia G; Lan L; Liu F; Wang Y; Liu B; Ding Y; Dai L; Zhang Y Intern Med; 2016; 55(4):339-45. PubMed ID: 26875957 [TBL] [Abstract][Full Text] [Related]
14. Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma. Verma A; Chopra A; Lee YW; Bharwani LD; Asmat AB; Aneez DB; Akbar FA; Lim AY; Chotirmall SH; Abisheganaden J Curr Drug Discov Technol; 2016; 13(2):68-76. PubMed ID: 27216707 [TBL] [Abstract][Full Text] [Related]
15. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples. Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade. Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677 [TBL] [Abstract][Full Text] [Related]
17. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions. Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448 [TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion. Tian T; Li J; Hu W; Sun C; Zhou J J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967 [TBL] [Abstract][Full Text] [Related]